Casdin Capital portfolio
68 tracked investments, 12 on the map, $1.9B raised across the mapped portfolio.
- insitro
- Absci
- CodexisPost-IPO Equity
- 908 DevicesSeries E
- Imagen TechnologiesSeries C
- Apella
- Dyno Therapeutics
- Leyden LabsSeries B
- Nomic Bio
- Volta LabsSeries A
- Octave
- Multiply LabsSeries A
Also in the portfolio
- Nautilus Biotechnology
- Oxford Nanopore Technologies
- Beacon Biosignals
- 23andMe
- GeneDx
- Singular Genomics
- Genome Medical
- Resilience
- Asimov
- SomaLogic
- Flatiron Health
- Treeline Biosciences
- Deepcell
- MOMA Therapeutics
- Vineti
- Verve Therapeutics
- Verana Health
- Komodo Health
- Auron Therapeutics
- Flare Therapeutics
- Character Biosciences
- Revolution Medicines
- Avidity Biosciences
- Genomatica
- NeoGenomics
- Beam Therapeutics
- Exai Bio
- Genapsys
- TMRW Life Sciences
- Vanqua Bio
- C2i Genomics
- Ventus Therapeutics
- NanoCellect Biomedical
- Molecular Assemblies
- Mnemo Therapeutics
- Notch Therapeutics
- T-knife
- Depixus
- Exo Therapeutics
- LetsGetChecked
- Paige
- Adaptive Biotechnologies
- Black Diamond Therapeutics
- iVexSol
- Loop Medical
- ONI
- Standard BioTools
- Generation Bio
- Jounce Therapeutics
- Basilard BioTech
- Magenta Therapeutics
- Foundation Medicine
- MyoKardia